Navigation Links
Natus Neurology Incorporated Receives 510(k) & Health Canada Clearance And Launches New Electrodiagnostic System In U.S. & Canada

MIDDLETON, Wis., Aug. 14, 2013 /PRNewswire/ -- Natus Neurology Incorporated, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and Health Canada clearance for its new electrodiagnostic system, the UltraPro S100 EMG System. The UltraPro S100 is an EMG/Nerve Conduction device for monitoring and testing electrophysiologic and electrodiagnostic information from the human nervous and muscular system.

"We are excited to bring the new UltraPro S100 EMG System to the U.S. & Canadian markets," said Austin Noll, Vice President and General Manager of Natus Medical Incorporated. "The UltraPro S100 helps strengthen our market-leading EMG portfolio and ensures clinicians and patients can benefit from the latest advancements in neurological care."

Built on the 60-year heritage of Nicolet, Dantec, XLTEK and Teca brands, the UltraPro S100 brings reliability, performance, portability and exceptional value to U.S. & Canadian clinicians.  It features easy-to-use reports, efficient connectivity to electronic medical records, distinctive function keys, online summaries and a built-in reference value database. 

Designed with input from neurologists and electrodiagnostic technicians, UltraPro S100 helps improve workflow in busy clinical settings by effectively organizing data into a variety of automated reporting formats. With this versatile system, clinicians can complete their studies and generate reports with ease, helping to streamline workflow, improving clinician efficiency and lowering costs.

The UltraPro S100 EMG System is now available to order and ship immediately to U.S. & Canadian customers. It will be featured at the Natus Neurology booth at leading U.S. & Canadian trade shows throughout the year.

Natus Medical Incorporated (NASDAQ: BABY) is a leading provider of medical devices, software and services for the Newborn Care, Neurology, Sleep, Hearing and Balance markets. Natus products are used in hospitals, clinics and laboratories world-wide. For more information about Natus, please visit


SOURCE Natus Medical Incorporated
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. CareFusion to Sell Neurodiagnostic Business to Natus Medical for $58 Million
2. Conatus Pharmaceuticals Appoints Daniel Ripley As Head Of Corporate Development
3. Conatus Pharmaceuticals Inc. Files Registration Statement for Proposed Initial Public Offering
4. Interim results of VITOBA™ (VImpaT® added to One Baseline AED) Study Presented at the 64th Annual Meeting of the American Academy of Neurology
5. Merz, Inc. Announces Cynthia Schwalm as Vice President, Neurology
6. Emerging Data From Upsher-Smiths CNS Portfolio Highlighted At 2013 American Academy Of Neurology Meeting
7. Data on ElectroCores Vagal Nerve Stimulation Therapy GammaCore Selected for an Oral Presentation at the 65th American Academy of Neurology Annual Meeting
8. The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Gen-Probe Incorporated in Connection with the Sale of the Company to Hologic, Inc.
9. Insmed Incorporated Announces Lifting of Clinical Hold by U.S. Food and Drug Administration on ARIKACE® in Cystic Fibrosis Patients With Pseudomonas Lung Infections
10. Insmed Incorporated Begins Screening Patients For TARGET-NTM U.S. Clinical Trial Of ARIKACE® In Patients With Non-tuberculous Mycobacterial Lung Disease
11. Faruqi & Faruqi, LLP Announces Investigation of ViroPharma Incorporated
Post Your Comments:
(Date:6/23/2016)... 23, 2016 Research and Markets has ... - Forecast to 2022" report to their offering. ... for the patients with kidney failure, it replaces the function ... the patient,s blood and thus the treatment helps to keep ... in balance. Increasing number of ESRD patients ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... WAYNE, Pa. , June 23, 2016 ... provider, will launch its next generation clinical outcomes platform, Bracket ... DIA Meeting held on June 26 – 30, 2016 in ... 6.0, the first electronic Clinical Outcome Assessment product of its ... DIA Booth #715. Bracket eCOA 6.0 is a ...
Breaking Medicine Technology:
(Date:6/27/2016)... Viejo, California (PRWEB) , ... June 27, 2016 , ... ... are fully customizable inside of Final Cut Pro X," said Christina Austin - CEO ... another unique style. Final Cut Pro X users can now reveal the ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... its strategic partnership with Connance, a healthcare industry leader providing predictive analytics ... proprietary technology combine to provide health systems, hospitals and ambulatory surgical centers ...
(Date:6/27/2016)... , ... June 27, 2016 , ... recently awarded ... Eyeglasses . , Millions of individuals in the United States and Canada wear ... a way to both correct vision and make a fashion statement. Even celebrities use ...
(Date:6/26/2016)... Battle Creek, Michigan (PRWEB) , ... June 26, 2016 , ... ... abuse, joined as sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table ... held in honor of the city’s history as home to some of the world’s ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned ... developed to enhance the health of felines. The formula is all-natural and is made ... in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root ...
Breaking Medicine News(10 mins):